4175tr human triple negative breast cancer cells Search Results


4175tr human triple negative breast cancer cells  (ATCC)
99
ATCC 4175tr human triple negative breast cancer cells
( a , b ) Trex1 expression and cytoplasmic dsDNA accumulations in MDA-MB-231 ( a ) and <t>4175TR</t> ( b ) breast carcinoma cells 24 hrs after in vitro treatment. Duplicate; * P <0.05; ** P <0.005; *** P <0.0005: t -test; n =3. All data are mean±s.e.m. ( c ) Trex1 , Ifnb1 and Mx1 expression measured by qRT-PCR in a patient-derived tumour xenograft (PDTX) 24 h after mice treatment with tumour-directed radiation. Duplicate; * P <0.05; ** P <0.005; *** P <0.0005: t -test; n =4. All data are mean±s.e.m.
4175tr Human Triple Negative Breast Cancer Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/4175tr human triple negative breast cancer cells/product/ATCC
Average 99 stars, based on 1 article reviews
4175tr human triple negative breast cancer cells - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
nup153 (6c1) monoclonal antibody  (Bioss)
N/A
Component of the nuclear pore complex (NPC), a complex required for the trafficking across the nuclear envelope. Functions as a scaffolding element in the nuclear phase of the NPC essential for normal nucleocytoplasmic transport of
   Buy from Supplier
scx antibody (pcrp-scxa-1d2) [dylight 550]  (Novus Biologicals)
N/A
The SCX Antibody (PCRP-SCXA-1D2) [DyLight 550] from Novus is a SCX antibody to SCX. This antibody reacts with Human. The SCX antibody has been validated for the following applications: Flow Cytometry, Immunocytochemistry/ Immunofluorescence.
   Buy from Supplier
p53 antibody (rtp53/8993) [dylight 550]  (Novus Biologicals)
N/A
The p53 Antibody (rTP53/8993) [DyLight 550] from Novus is a p53 antibody to p53. This antibody reacts with Human. The p53 antibody has been validated for the following applications: Immunohistochemistry-Paraffin.
   Buy from Supplier
arc/nol3 antibody [dylight 550]  (Novus Biologicals)
N/A
The ARC/NOL3 Antibody [DyLight 550] from Novus is a ARC/NOL3 antibody to ARC/NOL3. This antibody reacts with Human. The ARC/NOL3 antibody has been validated for the following applications: Western Blot, ELISA, Immunohistochemistry, Immunohistochemistry-Paraffin.
   Buy from Supplier
scx antibody (pcrp-scxa-1d2) [dylight 680]  (Novus Biologicals)
N/A
The SCX Antibody (PCRP-SCXA-1D2) [DyLight 680] from Novus is a SCX antibody to SCX. This antibody reacts with Human. The SCX antibody has been validated for the following applications: Flow Cytometry, Immunocytochemistry/ Immunofluorescence.
   Buy from Supplier
p53 antibody (rtp53/8993) [dylight 680]  (Novus Biologicals)
N/A
The p53 Antibody (rTP53/8993) [DyLight 680] from Novus is a p53 antibody to p53. This antibody reacts with Human. The p53 antibody has been validated for the following applications: Immunohistochemistry-Paraffin.
   Buy from Supplier
p53 antibody (rtp53/8993) [dylight 755]  (Novus Biologicals)
N/A
The p53 Antibody (rTP53/8993) [DyLight 755] from Novus is a p53 antibody to p53. This antibody reacts with Human. The p53 antibody has been validated for the following applications: Immunohistochemistry-Paraffin.
   Buy from Supplier
scx antibody (pcrp-scxa-1d2) [dylight 755]  (Novus Biologicals)
N/A
The SCX Antibody (PCRP-SCXA-1D2) [DyLight 755] from Novus is a SCX antibody to SCX. This antibody reacts with Human. The SCX antibody has been validated for the following applications: Flow Cytometry, Immunocytochemistry/ Immunofluorescence.
   Buy from Supplier

Image Search Results


( a , b ) Trex1 expression and cytoplasmic dsDNA accumulations in MDA-MB-231 ( a ) and 4175TR ( b ) breast carcinoma cells 24 hrs after in vitro treatment. Duplicate; * P <0.05; ** P <0.005; *** P <0.0005: t -test; n =3. All data are mean±s.e.m. ( c ) Trex1 , Ifnb1 and Mx1 expression measured by qRT-PCR in a patient-derived tumour xenograft (PDTX) 24 h after mice treatment with tumour-directed radiation. Duplicate; * P <0.05; ** P <0.005; *** P <0.0005: t -test; n =4. All data are mean±s.e.m.

Journal: Nature Communications

Article Title: DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity

doi: 10.1038/ncomms15618

Figure Lengend Snippet: ( a , b ) Trex1 expression and cytoplasmic dsDNA accumulations in MDA-MB-231 ( a ) and 4175TR ( b ) breast carcinoma cells 24 hrs after in vitro treatment. Duplicate; * P <0.05; ** P <0.005; *** P <0.0005: t -test; n =3. All data are mean±s.e.m. ( c ) Trex1 , Ifnb1 and Mx1 expression measured by qRT-PCR in a patient-derived tumour xenograft (PDTX) 24 h after mice treatment with tumour-directed radiation. Duplicate; * P <0.05; ** P <0.005; *** P <0.0005: t -test; n =4. All data are mean±s.e.m.

Article Snippet: MDA-MB-231 and 4175TR human triple negative breast cancer cells were purchased from ATCC and obtained from J. Massague, respectively.

Techniques: Expressing, In Vitro, Quantitative RT-PCR, Derivative Assay